Amplify Weight Loss Drug & Treatment ETF (THNR) Holdings List

$25.60 -0.40 (-1.54%)

As of 11:48 AM Eastern

What stocks does THNR hold?

The Amplify Weight Loss Drug & Treatment ETF (THNR) top stock holdings include Novo Nordisk A/S, Eli Lilly and Company, and Regeneron Pharmaceuticals. The top 22 THNR holdings ordered by weight make up 100.03% of the total fund. THNR is an equity fund in the strategy category that invests in publicly traded companies and other investments, focused on theme strategies within the Global region. This page includes a complete THNR stock holdings list ranked by weight, along with a full breakdown of sector, geographic, industry, and currency exposure.

Top 22 THNR Holdings

Rank	Company	Current Price	Weight	Shares Held
1	NVO Novo Nordisk A/S	$38.66 +1.3%	9.25%	10,466
2	LLY Eli Lilly and Company	$1,184.73 +2.9%	9.08%	397
3	REGN Regeneron Pharmaceuticals	$805.18 +0.4%	6.13%	402
4	Innovent Biologics, Inc.	N/A	5.85%	25,500
5	CSPC Pharmaceutical Group Limited	N/A	5.54%	260,000
6	AMGN Amgen	$409.55 +0.9%	5.48%	694
7	SRRK Scholar Rock	$48.83 -2.0%	5.36%	5,340
8	ARWR Arrowhead Pharmaceuticals	$65.96 -1.5%	5.19%	3,207
9	Roche Holding AG	N/A	5.11%	605
10	MRK Merck & Co., Inc.	$151.03 +2.0%	5.07%	1,977
11	ABBV AbbVie	$266.21 +0.4%	5.04%	1,062
12	PFE Pfizer	$28.72 +1.9%	4.75%	9,377
13	VKTX Viking Therapeutics	$36.28 -12.9%	4.51%	7,239
14	HIMS Hims & Hers Health	$27.73 -2.3%	4.50%	8,264
15	Chugai Pharmaceutical Co., Ltd.	N/A	4.35%	5,100
16	Zealand Pharma A/S	N/A	4.03%	4,047
17	AstraZeneca PLC	N/A	4.01%	1,348
18	Hanmi Pharm. Co., Ltd.	N/A	2.13%	402
19	Jiangsu Hengrui Pharmaceuticals Co.,Ltd	N/A	2.09%	15,800
20	KLRA Kailera Therapeutics	$12.65 -3.7%	1.95%	5,732
21	Invesco Short-Term Investments Trust Government & Agency Portfolio Institutional Class	N/A	0.37%	19,635
22	OTHER ASSETS AND LIABILITIES	N/A	0.24%	202,432,169

THNR Geographic Exposure

THNR's largest geographic exposure is United States at 65.0%, followed by Cayman Islands at 5.4%.

United States
65.0%
Cayman Islands
5.4%
Hong Kong
5.4%
United Kingdom
5.2%
Japan
5.0%
Denmark
3.9%
Korea, Republic of
3.5%

THNR Currency Exposure

THNR's largest currency exposure is USD at 75.4%, followed by HKD at 13.0%.

USD
75.4%
HKD
13.0%
JPY
5.0%
DKK
3.9%
KRW
3.5%

THNR Sector Exposure

THNR's largest sector exposure is Health Care at 91.2%.

Health Care
91.2%

THNR Industry Exposure

THNR's largest industry exposure is Biotechnology at 87.5%, followed by Pharmaceuticals at 3.7%.

Biotechnology
87.5%
Pharmaceuticals
3.7%

THNR Sub-Industry Exposure

THNR's largest sub-industry exposure is Biotechnology at 87.5%, followed by Pharmaceuticals at 3.7%.

Biotechnology
87.5%
Pharmaceuticals
3.7%

Related Companies and Tools

Related Companies

MarketBeat tracks Amplify Weight Loss Drug & Treatment ETF holdings and portfolio composition, last updated on 9/12/2026.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Amplify Weight Loss Drug & Treatment ETF (THNR) Holdings List